A veteran Bay Area biotech chief financial officer and a former investment bank analyst have joined CardioDx Inc. in senior management jobs.
Andrew Guggenhime, who was CFO of Facet Biotech Corp. and PDL BioPharma Inc. in Redwood City, joined CardioDx in the same position, the company said Monday. Dr. Mark Monane, formerly managing director of equity research at Needham & Co. for 11 years, joined CardioDx as chief medical officer.
No comments:
Post a Comment